Scientists at St. Jude Children’s Research Hospital have revealed how Fanzor2’s divergence from bacterial ancestors may make it a useful tool for future genomic engineering endeavors. Scientists at St. Jude Children’s Research Hospital have revealed how Fanzor2’s divergence from bacterial ancestors may make it a useful tool for future genomic engineering endeavors. Biotechnology Molecular & Computational biology Phys.org – latest science and technology news stories
Structure of a eukaryotic CRISPR-Cas homolog, Fanzor2, shows promise for gene editing
